tirzepatide week 4 weight loss percent In adults with obesity but not diabetes, leads to significantly greater than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Higher Doses= More Weight Loss?

You can return to your day immediately after the injection

Functional role of mitochondrial respiratory supercomplexes

Why is medical director oversight important for GLP-1 clinics

This slower approach allows the body to adjust to the new dual-receptor stimulation and helps minimize potential gastrointestinal side effects during the first few weeks

Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study

This study strengthens the argument for long-term, guideline-consistent obesity treatment and proactive conversations with patients about expectations, durability, and the chronic nature of care